Astro-Med, Inc. (ALOT) - 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated May 20, 2003, reports unaudited financial results for Astro-Med, Inc. for the first quarter of fiscal year 2004, ending May 3, 2003. The company manufactures high-tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments.
Key Financial Metrics
| Metric | Q1 FY2004 | Q1 FY2003 |
|---|---|---|
| Net Sales | $13,214,000 | $11,438,000 |
| Net Income (Loss) | $506,000 | $(632,000) |
| EPS (Basic & Diluted) | $0.12 | $(0.15) |
| Operating Profit Margin | 3.8% | Filing text does not provide a clear value |
| Operating Cash Flow | $783,000 | Filing text does not provide a clear value |
| Dividends Per Share | $0.04 | $0.04 |
Debt levels and liquidity ratios are not explicitly quantified in the filing text, though management noted positive results from working capital management.
Material Changes
- Profitability Turnaround: The company shifted from a net loss of $632,000 in the prior year quarter to a net income of $506,000.
- Revenue Growth: Net sales increased by approximately 15.5% year-over-year.
- Order Backlog: Incoming new orders reached a record $15 million, driven in part by a recently announced Airbus order.
- Margin Expansion: Gross profit margins rose notably, contributing to a 3.8% operating profit margin.
Outlook, Commentary, and Risks
CEO Albert W. Ondis expressed satisfaction with the results, citing strong market reception for new products. Management plans to continue focusing on sales growth through aggressive new product development and maintaining a controlled cost structure. A regular quarterly cash dividend of $0.04 per share was declared, payable July 1, 2003.
Risks: The filing includes a Safe Harbor statement noting that actual results may vary from forward-looking statements due to factors outlined in the company's annual report and other SEC filings.
Investor Verification Checklist
- Verify the details and value of the "Airbus order" mentioned as a driver for record new orders.
- Confirm the specific gross profit margin percentage, as only the operating margin (3.8%) is explicitly stated.
- Review the full balance sheet in the 10-Q or 10-K to assess debt levels and total liquidity, which are not detailed in this 8-K.
- Monitor the upcoming conference call on May 21, 2003, for further guidance on the "aggressive new product development" strategy.